NCT04440982: An ongoing trial by Lumicell, Inc.
This trial is completed, but has been granted a delay in reporting its results.
It must report results 11 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04440982 |
|---|---|
| Title | Feasibility Study to Evaluate Performance of the LUM Imaging System for Intraoperative Detection of Residual Tumor in Breast Cancer Patients Receiving and Not Receiving Neoadjuvant Therapy |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 1, 2020 |
| Completion date | Nov. 30, 2023 |
| Required reporting date | Nov. 30, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |